Loading clinical trials...
Loading clinical trials...
Pregnancy is a major risk factor of thromboembolic disease (2 to 10 increased risk of thromboembolic event for pregnant women). This risk is related to the physiological changes inducing venous stasis...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Central Hospital, Nancy, France
NCT05684770 · Thromboembolic Disease
NCT04861506 · Thromboembolic Disease, Lower Extremity Problem, and more
NCT06575309 · Pregnant Women, Venous Thromboembolic Disease
NCT06232551 · Venous Thromboembolic Disease, Pulmonary Embolism and Thrombosis, and more
NCT06855394 · Atherosclerotic Vascular Disease, Coronary Arterial Disease (CAD), and more
Nancy teaching hospital
Nancy
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions